Jeffrey Molter named director of communications at NYU Perlmutter Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jeffrey Molter joined NYU Langone Medical Center in a newly-created position of director of cancer center communications of its Laura and Isaac Perlmutter Cancer Center.Molter comes to Perlmutter after serving for the past four years as director of media and public relations for the American Association for Cancer Research in Philadelphia.“Jeff will team up with the Department of Marketing & Communications to plan, implement and manage communication initiatives for our rapidly growing Perlmutter Cancer Center,” said Kathy Lewis, senior vice president for Marketing & Communications at NYU Langone.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.
In January, FDA released a draft guidance entitled “Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints to Support Accelerated Approval.” This release came roughly 20 months after the Oncologic Drugs Advisory Committee (ODAC) voted unanimously that minimal residual disease (MRD) negativity, in combination with complete response (CR), is an acceptable primary endpoint to support accelerated approval for multiple myeloma (MM) therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login